International Journal of Clinical Research

Objective To analyze the effect of using Xuezhikang+atorvastatin in the treatment of hypertension combined with coronary heart disease. Methods A study was conducted on patients with hypertension and coronary heart disease in our hospital. A total of 50 cases were selected and the time period was from October 2023-June 2024. The patients were divided into two groups based on numerical sorting: the control group (25 cases with even numbers) was treated with atorvastatin, and the observation group (25 cases with odd numbers) was treated with Xuezhikang. The cardiac function indicators, blood pressure indicators, and adverse reactions of the two groups were compared. Results Compared with the control group, the observation group had better cardiac function and blood pressure indicators, and the differences were statistically significant (P<0.05). There was no statistically significant adverse reaction (P>0.05). Conclusion The treatment of hypertension combined with coronary heart disease using Xuezhikang+atorvastatin has a better effect, is more conducive to improving heart function and blood pressure indicators, does not increase adverse reactions, has high safety, and is more conducive to promoting body recovery.

Xuezhikang; Atorvastatin; hypertension; Coronary heart disease; Treatment